Will be interesting to see how much clinical sales are effected in response to this becoming a retail brand now. Practitioners don't like this and it will cause a drop off in clinical prescriptions which is generally what drives retail sales.
Medlab reps had previously assured practitioners they would not go into retail so they are going down the route of bioceuticals (which the founder of medlab also previously owned and sold...for a very high price)
- Forums
- ASX - By Stock
- MDC
- Ann: Medlab to Expand Nutraceutical Range into 2,100 Pharmacies
Ann: Medlab to Expand Nutraceutical Range into 2,100 Pharmacies, page-16
Add MDC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$6.60 |
Change
0.000(0.00%) |
Mkt cap ! $15.07M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
MDC (ASX) Chart |
Day chart unavailable